Brief: Abivax Nets $920 Mln In Gross Proceeds From ADS Offering

Abivax SA

02/07/2026 07:07

July 2 (Reuters) - Abivax SA ABVX.PA:
ANNOUNCES FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL ADSS, BRINGING GROSS PROCEEDS OF OFFERING TO $920M (€807M)
TOTAL 7.36 MILLION ADSS ISSUED; GROSS PROCEEDS $920 MILLION, NET PROCEEDS $874.1 MILLION
PROCEEDS TO BE USED FOR POTENTIAL COMMERCIALIZATION OF OBEFAZIMOD IN U.S. AND CLINICAL RESEARCH EXPENSES
ADDITIONAL ADSS EXPECTED TO BE DELIVERED WITH OFFERING CLOSING ON JULY 6, 2026
Source text: ID:nEQ8p4YVma
Further company coverage: ABVX.PA

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))